CHIZF vs MRK: Which Stock is Better?
Side-by-side comparison of China Traditional Chinese Medicine Holdings Co. Limited and Merck & Co Inc in 2026
CHIZF
China Traditional Chinese Medicine Holdings Co. Limited
$0.27
MRK
Merck & Co Inc
$117.10
Key Metrics Comparison
| Metric | CHIZF | MRK | Winner |
|---|---|---|---|
| Market Cap | $1.38B | $294.39B | MRK |
| P/E Ratio | N/A | 16.36 | MRK |
| EPS (TTM) | $N/A | $7.28 | MRK |
| Revenue Growth | -0.1% | 0.1% | MRK |
| Gross Margin | 48.1% | 77.2% | MRK |
Analyze CHIZF
Full quant analysis
Analyze MRK
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHIZF or MRK a better investment?
Comparing CHIZF and MRK: China Traditional Chinese Medicine Holdings Co. Limited has a market cap of $1.38B while Merck & Co Inc has $294.39B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHIZF and MRK?
CHIZF (China Traditional Chinese Medicine Holdings Co. Limited) and MRK (Merck & Co Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHIZF or MRK?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHIZF or MRK?
MRK has higher revenue growth at 0.1% vs -0.1% for CHIZF.
Which company is more profitable: CHIZF or MRK?
Merck & Co Inc (MRK) has higher gross margins at 77.2% compared to 48.1% for CHIZF.
Which is the larger company: CHIZF or MRK?
Merck & Co Inc (MRK) is larger with a market cap of $294.39B compared to $1.38B for CHIZF.
Should I buy CHIZF or MRK in 2026?
Both CHIZF and MRK have investment merit. CHIZF trades at $0.27 while MRK trades at $117.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHIZF and MRK stock?
Key differences: Market Cap ($1.38B vs $294.39B), P/E Ratio (N/A vs 16.4x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (48.1% vs 77.2%).